Lavinia La Grasta Sabolić

Dr. Lavinia La Grasta Sabolić


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
LSLavinia La Grasta Sabolić
Lavinia La Grasta Sabolić
MŠMarija Požgaj Šepec
Marija Požgaj Šepec
Maja Cigrovski BerkovicMaja Cigrovski Berkovic
Maja Cigrovski Berkovic
GSGordana Stipančić
Gordana Stipančić
Characteristics of the glucose response during oral glucose tolerance test (OGTT) may reflect differences in insulin secretion and action. We aimed to examine whether timing of the glucose peak, shape of the glucose curve and their combination could be indicators of beta-cell dysfunction in obese/severely obese adolescents with normal glucose tolerance (NGT). Data from 246 obese/severely obese adolescents who completed OGTT were reviewed. Out of 184 adolescents with NGT, 174 could be further classified into groups based on timing of the glucose peak (early/30 minutes vs late/≥60 minutes) and shape of the glucose curve (monophasic vs biphasic). Groups were compared with respect to insulin sensitivity (whole body insulin sensitivity index, WBISI), early-phase insulin secretion (insulinogenic index, IGI) and beta-cell function relative to insulin sensitivity (oral disposition index, oDI). Late glucose peak (p=0.004) and monophasic glucose curve (p=0.001) were both associated with lower oDI after adjustment for age, sex, puberty stage and body mass index (BMI) z-score. Among obese/severely obese adolescents with NGT, those with coexistent late glucose peak and monophasic glucose curve had lower oDI than those with early glucose peak and biphasic glucose curve (p=0.002). Moreover, a combination of late glucose peak and monophasic glucose curve was the most powerful predictor of the lowest oDI quartile (OR: 11.68, 95% CI: 3.048-44.755, p<0.001). Late timing of the glucose peak, monophasic shape of the glucose curve and in particular combination of those characteristics during OGTT may indicate early beta-cell dysfunction in obese/severely obese adolescents with NGT.

31 December 2022 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
BMBernardica Valent Morić
Bernardica Valent Morić
IŠIvan Šamija
Ivan Šamija
LSLavinia La Grasta Sabolić
Lavinia La Grasta Sabolić
GSGordana Stipančić
Gordana Stipančić
Purpose: To examine the characteristics of ambulatory blood pressure (ABP) including blood pressure variability (BPV) and its association with albuminuria in type 1 diabetic (T1D) children and to identify potential predictors of high-normal albuminuria and microalbuminuria.Methods: ABP monitoring was performed in 201 T1D children and adolescents (mean age, 14.7±3.8 years) with T1D duration over 1 year. The level of albuminuria was assessed as the albumin/creatinine ratio (ACR) and patients were further classified as low-normal, high-normal or microalbuminuria.Results: Fifteen T1D children (7.5%) were hypertensive using office blood pressure (BP) and 10 (5%) according to ABP. T1D subjects had elevated 24-hour systolic BP (SBP) and diastolic BP (DBP) (+0.2 and + 0.3 standard deviation score [SDS]) and nighttime SBP and DBP (+0.6 and +0.8 SDS) compared to reference values. Patients with microalbuminuria had significantly higher 24-hour, daytime and nighttime DBP compared to normoalbuminuric subjects. There was a high percentage of nondippers (74.1%). Nighttime diastolic BPV was significantly higher in subjects with high-normal compared to low-normal albuminuria (p=0.01). A weak correlation was found between ACR and daytime DBP SDS (r=0.29, p<0.001 and nighttime DBP SDS (r=0.21, p=0.003). Age and nighttime diastolic BPV were predictors of high-normal albuminuria while nighttime DBP was a strong predictor for microalbuminuria.Conclusion: T1D children have impaired BP regulation although most of them do not fulfill the criteria for sustained hypertension. There is an association between diastolic ABP and diastolic BPV with rising levels of albuminuria pointing to a clear connection between BP and incipient diabetic nephropathy.

15 July 2023 in World Journal of Diabetes
Verified
Journal Article
Open access
LSLavinia La Grasta Sabolić
Lavinia La Grasta Sabolić
MSMarija Pozgaj Sepec
Marija Pozgaj Sepec
BMBernardica Valent Moric
Bernardica Valent Moric
MBMaja Cigrovski Berkovic
Maja Cigrovski Berkovic
An association between cardiorespiratory fitness (CRF) and insulin resistance in obese adolescents, especially in those with various obesity categories, has not been systematically studied. There is a lack of knowledge about the effects of CRF on insulin resistance in severely obese adolescents, despite their continuous rise. To investigate the association between CRF and insulin resistance in obese adolescents, with special emphasis on severely obese adolescents. We performed a prospective, cross-sectional study that included 200 pubertal adolescents, 10 years to 18 years of age, who were referred to a tertiary care center due to obesity. According to body mass index (BMI), adolescents were classified as mildly obese (BMI 100% to 120% of the 95th percentile for age and sex) or severely obese (BMI ≥ 120% of the 95th percentile for age and sex or ≥ 35 kg/m2, whichever was lower). Participant body composition was assessed by bioelectrical impedance analysis. A homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. Maximal oxygen uptake (VO2max) was determined from submaximal treadmill exercise test. CRF was expressed as VO2max scaled by total body weight (TBW) (mL/min/kg TBW) or by fat free mass (FFM) (mL/min/kg FFM), and then categorized as poor, intermediate, or good, according to VO2max terciles. Data were analyzed by statistical software package SPSS (IBM SPSS Statistics for Windows, Version 24.0). P < 0.05 was considered statistically significant. A weak negative correlation between CRF and HOMA-IR was found [Spearman’s rank correlation coefficient (rs) = -0.28, P < 0.01 for CRFTBW; (rs) = -0.21, P < 0.01 for CRFFFM]. One-way analysis of variance (ANOVA) revealed a significant main effect of CRF on HOMA-IR [F(2200) = 6.840, P = 0.001 for CRFTBW; F(2200) = 3.883, P = 0.022 for CRFFFM]. Subsequent analyses showed that obese adolescents with poor CRF had higher HOMA-IR than obese adolescents with good CRF (P = 0.001 for CRFTBW; P = 0.018 for CRFFFM). Two-way ANOVA with Bonferroni correction confirmed significant effect of interaction of CRF level and obesity category on HOMA-IR [F(2200) = 3.292, P = 0.039 for CRFTBW]. Severely obese adolescents had higher HOMA-IR than those who were mildly obese, with either good or poor CRF. However, HOMA-IR did not differ between severely obese adolescents with good and mildly obese adolescents with poor CRF. CRF is an important determinant of insulin resistance in obese adolescents, regardless of obesity category. Therefore, CRF assessment should be a part of diagnostic procedure, and its improvement should be a therapeutic goal.

11 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LSLavinia La Grasta Sabolić
Lavinia La Grasta Sabolić
AKAna Kovačević
Ana Kovačević
MSMarija Pozgaj Sepec
Marija Pozgaj Sepec
AUAnita Spehar Uroic
Anita Spehar Uroic
ASAna Smolić
Ana Smolić
BMBernardica Valent Morić
Bernardica Valent Morić
Background and Objectives: Emerging clinical data indicate that glucose levels in women with type 1 diabetes (T1D) fluctuate throughout the menstrual cycle. However, data concerning the adolescent population remain sparse. This study aimed to compare continuous glucose monitoring (CGM)-derived glycemic metrics between the early follicular and late luteal phases in adolescent girls with T1D in order to establish a clinical basis for phase-specific treatment adjustments. Materials and Methods: Ninety-nine menstrual cycles from 34 female adolescents with T1D were retrospectively analyzed. Time in range (TIR), time above range (TAR), time below range (TBR), mean glucose, and glucose variability were compared between the early follicular and late luteal phases. Additional analyses were performed to evaluate the impact of different insulin delivery methods and to assess glycemic metrics across subgroups by glycemic control. Results: During the late luteal phase, TIR was significantly lower, while TAR and mean glucose were significantly higher compared to the early follicular phase (p < 0.05). Although the continuous subcutaneous insulin infusion (CSII) group achieved better overall glycemic metrics then the multiple daily injections (MDI) group, phase-related fluctuations in TIR and TAR reached significance precisely within the CSII group. Furthermore, glycemic shifts in TAR, TBR and mean glucose were especially pronounced in adolescents with tight glycemic control (HbA1c < 7.0%). Conclusions: The late luteal phase is associated with significant glycemic deterioration in adolescent girls with T1D, particularly in those with optimal glycemic control. These findings underscore the need for targeted education and menstrual-cycle-tailored insulin dose adjustments.

11 October 2021
Verified
Conference Paper
Open access
PDF file
MŠMarija Požgaj Šepec
Marija Požgaj Šepec
LSLavinia La Grasta Sabolić
Lavinia La Grasta Sabolić
MSMagdalena Avbelj Stefanija
Magdalena Avbelj Stefanija
JKJernej Kovač
Jernej Kovač
GSGordana Stipančić
Gordana Stipančić
Background Central precocious puberty (CPP) is defined by gonadotrophin-dependent development of secondary sex characteristics before the age of 8 in girls and 9 years in boys. Approximately 25% of CPP cases are familial, but its genetic cause often remains unknown. Mutations in makorin RING finger protein 3 gene (MKRN) are a common cause of familial CPP, being identified in 33-46 % of familial cases. We describe dizygotic twin sisters diagnosed with CPP and treated with gonadotrophin-releasing hormone agonists analog (GnRHa), in whom genetic analysis revealed the cause for CPP. Case Presentation A 6.4 year old girl presented with acne, pubic hair and body odour. Diagnosis of CPP was performed on the basis of clinical signs of central puberty (breast Tanner 2 and pubic hair Tanner 2), increased basal gonadotrophine hormones (LH 4.6 IU/L, FSH 3.7 IU/L, E2 109 pmol/L) and growth spurt (height on 1.6 SDS). Her bone age was assessed to be 7 years. Brain Magnetic Resonance (MRI) did not disclose any abnormality. Treatment with GnRHa was given subcutaneously once a month (triptorelin in a dose 3.75 mg). Girl’s dizygotic twin sister developed signs of puberty at the age of 8 years. At presentation, she had breast Tanner 3 and pubic hair Tanner 1. Her bone age was 8.6 years, her height was on 0.8 SDS. Laboratory assessment confirmed CPP (LH 1.07 IU/L, FSH 3.9 IU/L, E2 187 pmol/L ) and after additional endocrinological and neuroradiological work-up, suppression of CPP started. Precocious puberty was well controlled by pharmacological therapy and both sisters reached their final height (163.8 and 159.1 cm) in accordance with midparental height (MPH 165cm, 0.6 SDS). As CPP was diagnosed in both dyzygotic twin sisters, we sought for a genetic cause. Coding regions of the MKRN3 gene and exon-intron boundaries were analyzed using Sanger sequencing. Pathologic heterozygous variant NM_005664.3:3:c.475_476insC (NP_005655.1:p.Ala162Glyfs) of MKRN3 gene was identified in both siblings. Conclusion We want to highlight the importance of genetic analysis in cases od familial CPP, providing grounds for genetic counseling in later life.

11 October 2021
Verified
Conference Paper
Open access
PDF file
LSLavinia La Grasta Sabolić
Lavinia La Grasta Sabolić
MŠMarija Požgaj Šepec
Marija Požgaj Šepec
IZIvana Zec
Ivana Zec
DMDario Mandic
Dario Mandic
GSGordana Stipančić
Gordana Stipančić
Background Laboratory evaluation is crucial for accurate assessment of patients with endocrine disorders. When clinical picture is in obvious contradiction with laboratory results, one should suspect and prove analytical interference. Case presentation: a 6.7-year-old girl presented with sexual and axillary hair accompanied by adult-type body odor. She was tall (height SDS 2.6), with no other signs of virilisation and no breast development. Her bone age was slightly advanced (7.5 years), and laboratory workup showed markedly elevated levels of dehydroepiandrosterone sulphate (DHEAS), elevated testosteron and appropriate level of 17-hydroxyprogesterone (17-OHP) measured by electrochemical luminescence immunoassay (ECLIA). Subsequent investigations confirmed previous laboratory results, but also revealed elevated serum estradiol with no evidence of estrogen effect on uterus and no adrenal or adnexal mass. Cortisol level was unremarkable. During one year folow up, there were no changes in girl’s clinical appearance, while levels of her sex steroids determined by ECLIA fluctuated from undetectable or slightly elevated to markedly elevated. There were no apparent risk factors for analytic interference (no biotin supplementation or drugs, negative rheumatoid factor, no hypergammaglobulinemia). When samples were reanalyzed with the addition of a blocking agent, significantly lower levels of serum sex steroids were obtained, while liquid chromatography tandem mass spectrometry (LC-MS/MS) revealed sex steroids appropriate for age. Conclusion Laboratory interference is a drawback in hormonal testing. Clinicians should have that in mind when faced with laboratory results discordant with patient’s clinical presentation. Elevation of multiple sex steroid hormones in a prepubertal girl due to laboratory interference in immunoassay was finally unmasked by LC-MS/MS.